Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its Progression
Latest Information Update: 09 Feb 2024
Price :
$35 *
At a glance
- Drugs Dutasteride (Primary)
- Indications Prostate cancer
- Focus Biomarker; Pharmacodynamics; Pharmacogenomic
- 07 Feb 2024 Planned End Date changed from 1 Dec 2023 to 1 Dec 2024.
- 13 Feb 2023 Planned primary completion date changed from 1 Dec 2022 to 1 Dec 2023.
- 14 Mar 2022 Planned End Date changed from 1 Dec 2021 to 1 Dec 2023.